(2S,3S)-2-(((Benzyloxy)carbonyl)(methyl)amino)-3-methylpentanoic acid

95%

Reagent Code: #235025
fingerprint
CAS Number 42417-66-3

science Other reagents with same CAS 42417-66-3

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 279.33 g/mol
Formula C₁₅H₂₁NO₄
inventory_2 Storage & Handling
Storage 2-8°C

description Product Description

Used as an intermediate in the synthesis of pharmaceutical peptides, particularly in the preparation of protease inhibitors such as those targeting HIV. Its protected amine and carboxylic acid functionalities allow for selective coupling in solid-phase or solution-phase peptide synthesis. The stereochemistry supports the formation of biologically active conformations in final drug compounds. Commonly employed in research settings for developing enzyme inhibitors and bioactive molecules requiring specific chiral centers.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 250mg
10-20 days ฿1,160.00
inventory 1g
10-20 days ฿3,240.00
inventory 5g
10-20 days ฿13,190.00
(2S,3S)-2-(((Benzyloxy)carbonyl)(methyl)amino)-3-methylpentanoic acid
No image available

Used as an intermediate in the synthesis of pharmaceutical peptides, particularly in the preparation of protease inhibitors such as those targeting HIV. Its protected amine and carboxylic acid functionalities allow for selective coupling in solid-phase or solution-phase peptide synthesis. The stereochemistry supports the formation of biologically active conformations in final drug compounds. Commonly employed in research settings for developing enzyme inhibitors and bioactive molecules requiring specific

Used as an intermediate in the synthesis of pharmaceutical peptides, particularly in the preparation of protease inhibitors such as those targeting HIV. Its protected amine and carboxylic acid functionalities allow for selective coupling in solid-phase or solution-phase peptide synthesis. The stereochemistry supports the formation of biologically active conformations in final drug compounds. Commonly employed in research settings for developing enzyme inhibitors and bioactive molecules requiring specific chiral centers.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...